Correlation Between Salesforce and Santhera Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Salesforce and Santhera Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Santhera Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Santhera Pharmaceuticals Holding, you can compare the effects of market volatilities on Salesforce and Santhera Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Santhera Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Santhera Pharmaceuticals.
Diversification Opportunities for Salesforce and Santhera Pharmaceuticals
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Santhera is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Santhera Pharmaceuticals Holdi in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santhera Pharmaceuticals and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Santhera Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santhera Pharmaceuticals has no effect on the direction of Salesforce i.e., Salesforce and Santhera Pharmaceuticals go up and down completely randomly.
Pair Corralation between Salesforce and Santhera Pharmaceuticals
Considering the 90-day investment horizon Salesforce is expected to generate 0.99 times more return on investment than Santhera Pharmaceuticals. However, Salesforce is 1.01 times less risky than Santhera Pharmaceuticals. It trades about 0.41 of its potential returns per unit of risk. Santhera Pharmaceuticals Holding is currently generating about -0.26 per unit of risk. If you would invest 28,676 in Salesforce on August 25, 2024 and sell it today you would earn a total of 5,526 from holding Salesforce or generate 19.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Santhera Pharmaceuticals Holdi
Performance |
| Timeline |
| Salesforce |
| Santhera Pharmaceuticals |
Salesforce and Santhera Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Santhera Pharmaceuticals
The main advantage of trading using opposite Salesforce and Santhera Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Santhera Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santhera Pharmaceuticals will offset losses from the drop in Santhera Pharmaceuticals' long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Santhera Pharmaceuticals vs. Basilea Pharmaceutica AG | Santhera Pharmaceuticals vs. Idorsia | Santhera Pharmaceuticals vs. Newron Pharmaceuticals SpA | Santhera Pharmaceuticals vs. Evolva Holding SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |